Plus   Neg

Ligand Pharmaceuticals Inc. (LGND) Is Up Sharply After Q2 Profit Beat

Ligand Pharmaceuticals Inc. (LGND) reported second quarter EPS of $2.59 after the bell Monday, which surpassed the consensus estimate of $2.34. The stock is now up 12.16 on 7K shares.

Ligand Pharmaceuticals traded in a range for the bulk of Monday's session and closed up by 1.70 at $226.74.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT